...
机译:一线表皮生长因子受体(EGFR) - 单独或与血液血糖腺癌患者脑转移的全脑放射疗法
Wuhan Univ Hubei Gen Hosp Dept Clin Oncol Renmin Hosp 238 Jiefang Rd Wuhan 430060 Peoples R;
Angang Gen Hosp Dept Radiat Oncol Anyang Peoples R China;
Zhengzhou Univ Henan Canc Hosp Dept Radiat Oncol Affiliated Canc Hosp Zhengzhou Peoples R China;
Zhengzhou Univ Henan Canc Hosp Dept Radiat Oncol Affiliated Canc Hosp Zhengzhou Peoples R China;
Zhengzhou Univ Henan Canc Hosp Dept Radiat Oncol Affiliated Canc Hosp Zhengzhou Peoples R China;
Zhengzhou Univ Henan Canc Hosp Dept Radiat Oncol Affiliated Canc Hosp Zhengzhou Peoples R China;
Zhengzhou Univ Henan Canc Hosp Dept Radiat Oncol Affiliated Canc Hosp Zhengzhou Peoples R China;
Zhengzhou Univ Henan Canc Hosp Dept Radiat Oncol Affiliated Canc Hosp Zhengzhou Peoples R China;
Zhengzhou Univ Henan Canc Hosp Dept Radiat Oncol Affiliated Canc Hosp Zhengzhou Peoples R China;
Brain metastasis; EGFR mutation; lung adenocarcinoma; prognosis; radiotherapy;
机译:一线表皮生长因子受体(EGFR)-酪氨酸激酶抑制剂单独或与全脑放疗一起用于EGFR突变的肺腺癌患者的脑转移
机译:一线表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)联合全脑放疗对EGFR突变阳性肺腺癌和脑转移瘤的治疗作用
机译:一线表皮生长因子受体(EGFR)-酪氨酸激酶抑制剂单独或与全脑放疗一起用于EGFR突变型肺腺癌患者的脑转移
机译:喹唑啉衍生物作为表皮生长因子受体 - 酪氨酸激酶(EGFR-TK)抑制剂的QSAR研究
机译:酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
机译:全脑放疗与表皮生长因子受体酪氨酸激酶抑制剂的组合可改善EGFR突变的非小细胞肺癌脑转移患者的总体生存率。
机译:>全脑放射治疗可以改善由表皮生长因子受体 - 酪氨酸激酶抑制剂治疗的非小细胞肺癌的多脑转移患者的存活率 p>